If you have been diagnosed with treatment-resistant depression and are looking for Spravato treatment in Palm Beach County, NeuPath Mind Wellness offers supervised Spravato sessions across three conveniently located South Florida clinics in Delray Beach, Boca Raton, and Boynton Beach.
Spravato is the first and only FDA-approved nasal spray for treatment-resistant depression. It is covered by most major insurance plans, works faster than traditional antidepressants, and is administered in a supervised clinical setting that ensures both safety and therapeutic effectiveness. For Palm Beach County residents who have not found adequate relief from standard antidepressants, Spravato represents one of the most accessible advanced treatment options available today.
This post covers everything Palm Beach County patients need to know about Spravato, where to get it, how insurance works, and how to take the first step.
What Is Spravato and Why Does It Matter?
Spravato is the brand name for esketamine, a nasal spray form of ketamine developed specifically for treatment-resistant depression and approved by the FDA in 2019. It was the first genuinely new class of antidepressant approved in decades and marked a significant turning point in how psychiatry approaches patients who have not responded to standard medications.
Unlike traditional antidepressants which work by slowly adjusting serotonin or norepinephrine levels over weeks, Spravato works through the glutamate system and can produce meaningful antidepressant effects within hours to days of the first session. For patients who have spent months or years cycling through medications without finding relief, that speed of response is clinically significant.
Spravato is approved for two specific indications:
Treatment-resistant depression. Defined as major depressive disorder that has not responded adequately to at least two antidepressant trials at adequate doses and durations.
Major depressive disorder with acute suicidal ideation or behavior. Spravato is one of the few FDA-approved treatments specifically indicated for patients experiencing active suicidal ideation, reflecting its ability to produce rapid relief in urgent situations.
Who Is a Candidate for Spravato in Palm Beach County?
Spravato is most appropriate for patients who meet one or both of the FDA-approved indications described above. In practice, strong candidates typically include patients who:
- Have tried at least two antidepressants at therapeutic doses without adequate improvement
- Are experiencing significant functional impairment from depression despite ongoing treatment
- Need faster relief than standard antidepressants can provide
- Want an FDA-approved, insurance-eligible advanced treatment
- Have tried IV ketamine and want to transition to a covered maintenance option
- Are experiencing active suicidal ideation that requires rapid clinical intervention
If you are not sure whether you qualify, a free consultation with one of our NeuPath psychiatrists will give you a clear answer based on your specific clinical history.
NeuPath Mind Wellness offers supervised Spravato treatment across three Palm Beach County locations in Delray Beach, Boca Raton, and Boynton Beach. No referral is needed and free consultations are available at all three locations.
Strong candidates include patients who have tried at least two antidepressants without adequate improvement, are experiencing significant functional impairment despite ongoing treatment, need faster relief than standard antidepressants provide, or are experiencing active suicidal ideation requiring rapid intervention.
No. You can book a consultation directly with NeuPath without a referral from any other provider. The consultation is free and carries no obligation.
Spravato can produce meaningful antidepressant effects within hours to days of the first session, significantly faster than traditional antidepressants which take four to six weeks to produce effects.
How Spravato Treatment Works at NeuPath
Spravato is not a take-home medication. It is self-administered as a nasal spray under clinical supervision at one of our Palm Beach County clinic locations, followed by a mandatory two-hour observation period.
Here is what a Spravato session at NeuPath looks like:
Arrival and check-in. You arrive at the clinic and check in with our clinical team. Your blood pressure is checked before the session begins, as Spravato can transiently elevate blood pressure during and after administration.
Self-administration. You self-administer the Spravato nasal spray under the supervision of a trained clinician. The dose is either 56mg or 84mg depending on your treatment plan and your response to previous sessions.
Observation period. You remain in the clinic for two hours following administration. During this time you may experience dissociative symptoms, dizziness, nausea, or perceptual changes. These effects are transient and resolve during the observation period for most patients. You can rest, listen to music, or simply relax during this time.
Discharge. Once the observation period is complete and the clinical team confirms you are ready to leave, you are discharged. You cannot drive yourself home after a Spravato session. Plan to have a driver or arrange transportation.
Treatment frequency. Sessions are typically twice weekly for the first four weeks, then weekly for weeks five through eight, then every one to two weeks as a maintenance dose depending on your response.
Is Spravato Covered by Insurance in Palm Beach County?
Yes, for patients who meet clinical criteria. Spravato’s FDA approval gives it a clear insurance coverage pathway that IV ketamine does not have.
Insurance plans that commonly cover Spravato include:
- Aetna
- Blue Cross Blue Shield / Florida Blue
- Cigna and Evernorth
- UnitedHealthcare
- Humana
- Medicare Part D
- Most major commercial plans
Coverage typically requires a diagnosis of treatment-resistant depression and documentation of at least two failed antidepressant trials. Prior authorization is required by most plans before treatment begins.
At NeuPath, our team handles the entire insurance verification and prior authorization process on your behalf. You will know exactly what your plan covers before your first session. No surprises and no unexpected bills.
Yes, for patients who meet clinical criteria. Most major insurance plans cover Spravato for treatment-resistant depression including Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, Humana, and Medicare. NeuPath handles verification and prior authorization before treatment begins.
Cost varies depending on your treatment frequency and plan. Contact our team at NeuPath and we will verify your insurance benefits and provide a full cost breakdown before you commit to anything.
Spravato is a nasal spray using esketamine, is FDA-approved, and is typically covered by insurance. IV ketamine uses the full racemic ketamine molecule, offers more dosing flexibility, and may have a clinical edge for certain patients, but is generally not covered by insurance.
No. You cannot drive yourself home after a Spravato session. Plan to have a driver or arrange transportation. A two-hour observation period at the clinic is required after every session before you are discharged.
Spravato vs. IV Ketamine: Which Is Right for You?
Both Spravato and IV ketamine are available at NeuPath and both work through the same basic mechanism. The practical differences between them often drive the decision more than clinical efficacy data alone.
Choose Spravato if:
- Insurance coverage is a priority
- You prefer an FDA-approved treatment with an established regulatory pathway
- A milder dissociative experience is preferable
- You are transitioning from IV ketamine to a covered maintenance option
Choose IV ketamine if:
- You are willing to pay out of pocket and want maximum dosing flexibility
- You have had a partial response to Spravato and want to try the full racemic formulation
- Your psychiatrist believes the full ketamine molecule may offer additional benefit for your specific presentation
Our psychiatrists will help you determine which option makes the most clinical and practical sense for your situation during your free consultation.
Why Choose NeuPath for Spravato in Palm Beach County
NeuPath Mind Wellness is one of the few practices in Palm Beach County that offers Spravato alongside the full range of complementary advanced treatments including IV ketamine, TMS therapy, and GeneSight genetic testing. This matters because Spravato works best as part of a comprehensive treatment plan rather than in isolation.
If your Spravato response is strong but begins to fade over time, TMS therapy is available immediately within the same practice to build on and sustain your gains. If genetic testing reveals pharmacogenomic factors affecting your medication response, your psychiatrist can integrate those findings into your Spravato treatment plan without referring you elsewhere. The continuity of care that comes from having every treatment option available under one roof is a genuine clinical advantage.
All Spravato treatment at NeuPath is overseen by a board-certified psychiatrist who knows your full history and monitors your response at every session. You are not being managed by a remote prescriber or a rotating clinical team. You have one practice, one clinical team, and one coordinated plan.
| Getting Started With Spravato at NeuPath in Palm Beach County |
|---|
| The first step is a free consultation with one of our psychiatrists at any of our three Palm Beach County locations. During that conversation your psychiatrist will review your history, confirm whether you meet the criteria for Spravato, verify your insurance coverage, and walk you through what treatment looks like in practice. There is no referral needed and no obligation to proceed after the consultation. Our goal is simply to give you an honest, complete picture of your options. |
| Book your free consultation at NeuPath Mind Wellness in Delray Beach, Boca Raton, or Boynton Beach today. |
